BIO-RAD LABORATORIOS BRASIL LTDA.
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
Explore comprehensive manufacturer profile for BIO-RAD LABORATORIOS BRASIL LTDA. based in Brazil through Pure Global AI's free Brazil medical device database. This manufacturer has 14 products registered with ANVISA across 6 unique technical categories. Their regulatory history spans from Jul 14, 2025 to Aug 10, 2026.
This page provides detailed insights including 5 recent product registrations including ANTI-HUMAN GLOBULIN (COOMBS), 5 most popular products with IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN having 5 registrations, 1 registration holders including BIO-RAD LABORATORIOS BRASIL LTDA, and 5 key competitors with DIAGNOSTIC GRIFOLS, S.A. sharing 5 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.